2WHO.World survey of rabies No 35 for the year 1999.
3WHO Expert consultation on Rabies 2004.First Report.WHO-Technical Report Series 931.2005.http://www.who.int/rabies/trs931 # 0605.pdf.
4Dodet B,The Asian Rabies Expert Bureau.Preventing the incurable:Asian rabies experts advocate rabies control.Vaccine,2006,24:3045-3049.
5Wilde H,Hemachudha T.How far can the antigen content of tissue culture rabies vaccine be reduced safely.Vaccine,2006,24:1489.
6Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob (CJD) Disease and Variant Creutzfeldt-Jakob Disease by blood and blood product.Final FDA guidance document;www.fda.gov/cber/gdlns/cjdvcjdq&a.htm.
7Report of a WHO.Consultation on medicinal and other products in relation to human and animal transmissible spongiform encephalitis.WHO,1997.3.
8Note for guidance on production and quality control of animal immunoglobulins and immunosera for humanse.7 Westferry Circus,Canary Wharf,London,E144HB,UK.http://www.enea.eu.int.
9Khawplod P,Wilds H,Chomchey P,et al.What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine,1996,14:389-391.
